Skip to main content

Currently Skimming:

Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma
Pages 11302-11306

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 11302...
... Cell Biology and "Pathology, Howard Hughes Medical Institute, Baylor College of Medicine, Houston, TX 77030 ABSTRACT Recombinant adenoviral mediated delivery of suicide and cytokine genes has been investigated as a treatment for hepatic metastases of colon carcinoma in mice. Liver tumors were established by intrahepatic implantation of a poorly immunogenic colon carcinoma cell line (MCA-26)
From page 11303...
... Combination Suicide and IL-2 Gene Therapy for Hepatic Metastases of Colon Carcinoma. Adenoviral mediated gene transfer of mIL-2 into the tumor was synergistical with HSV-tk and induced a systemic antitumor immunity that resulted in the further regression of the hepatic tumor as well as protection against distant site challenges of parental tumor cells (18~.
From page 11304...
... IL-12 Mediated Gene Therapy of Metastatic Colon Carcinoma. IL-12 is known to enhance the cytolytic activity of a number of immune effecter cells including NK cells, lymphokine-activated killer cells, T cells and macrophages (21-24~.
From page 11305...
... This additional treatment can potentially enhance the antitumoral efficacy of IL-12 and induce a long-lasting systemic antitumoral immunity. The results obtained with a poorly immunogenic tumor are encouraging for the further development of in vivo gene therapy as a treatment modality for metastases from colon cancer in humans.
From page 11306...
... (1994) Cancer Res.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.